Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Half-year Report

30 Jun 2020 07:01

RNS Number : 4423R
Catenae Innovation PLC
30 June 2020
Β 

30 June 2020

Catenae Innovation PLC

("Catenae", the "Company" or the "Group")

Β 

Half-yearly report to 31 March 2020

Β 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, is pleased to announce its half-yearly report for the six months ended 31 March 2020.

Β 

Financial overview

Β 

Β· The results for the half year are set out in full below and show a loss of Β£364,013 (2018: Β£503,233) with revenues of Β£19,892 (2018: Β£68,857).

Β· Shareholders approved a consolidation of share capital which enabled a fund raise of Β£153,000 and conversion of Β£404,250 liabilities to shares resulting in an improved balance sheet with net liability position of Β£533,840 (2018: Β£399,980) compared to the year-end position of Β£727,077.

Β 

Operational overview

Β 

Β· Renewal of contract with Southend United Community and Educational Trust for "OnSide", Catenae's centralised management tool specifically developed for sports organisations.

Β 

Post period end

Β 

Β· Development of the Cov-ID app, a joint initiative by a consortium of companies led by Z/Yen Group Limited to build a COVID-19 status verification passport.

Β· Partnership agreement with Newcastle Premier Health Limited, an occupational health and wellness business based in the North East of England, to pilot the Cov-ID app

Β· Kevin Everett stepped down as Interim Non-executive Chairman

Β· Appointment of Brian Thompson and John Farthing to the Board as Non-executive Chairman and Chief Financial Officer respectively

Β· Appointment of Brandon Hill Capital Limited as sole corporate broker

Β· As at 26 June 2020 the Company had cash balance of just over Β£1.0m

Β 

Guy Meyer, Interim Chief Executive Officer of Catenae, said: "Significant progress has been made during the period under review towards implementing the Group's revised strategy following the corporate restructuring that took place in 2019, and we have seen this momentum continue to date.

Β 

"We are delighted that the Cov-ID app that Catenae has developed as its commercial contribution to the consortium led by Z/Yen Group Limited completed the recent pilot trail with our clinical partner, Newcastle Premier Health Limited, as part of their Access Control Programme. The app should shortly be ready to be marketed for the benefit of businesses and organisations as Covid-19 restrictions begin to ease.

Β 

"Our recent fundraises have provided us with the funds required to continue to explore further opportunities. We look forward to keeping the market updated with our progress."

Β 

Chief Executive's Statement

Β 

Business and performance review

Β 

Following the successful corporate restructuring and business stabilisation process carried out by the Board in 2019, Catenae was able to focus its efforts on delivering on its new strategy in the six months to 31 March 2020, by innovating its products and exploring new opportunities for growth. This positive momentum has continued post period end, with two new Board appointments and a number of projects underway.

Β 

Catenae's principal trading activity is providing services to clients operating in the Facilities Management sector along with customers, partnered with football and rugby clubs, who offer local engagement services on behalf of local authorities. All the Company's products use Distributed Ledger Technology which provides clients with immutable audit trails providing evidence that contracted services are fulfilled. The Company's service mitigates risk as operative activities are geo-tagged and date and time stamped in an immutable form.

Β 

As announced on 19 December 2019, the Company renewed its contract with Southend United Community and Educational Trust for "OnSide", Catenae's centralised management tool specifically developed for sports organisations. The solution deals with all the key elements of community coaching from scheduling of staff and timesheet processing through to attendee management and reporting to internal and external stakeholders, all in a GDPR compliant platform.

Β 

COVID-19

Β 

Post period end, the Company has been exploring a number of opportunities across a range of sectors to leverage its technical solutions. Catenae joined a consortium led by Z/Yen Group Limited ("Z/Yen") with the objective of building a GDPR-compliant identity documentation exchange system, "Cov-ID", to record and share an individual's Covid-19 test status. Considerable progress has been made in the development of the app, which was recently trialled by the Group's occupational health and wellness partner in the North East of England, Newcastle Premier Health Limited, in its proof of concept pilot. Catenae expects the app to be ready to be rolled out commercially over the coming weeks as activity begins to return to a semblance of normality.

Β 

Notwithstanding the current market developments in relation to the COVID-19 pandemic, the Company has confidence in its business continuity arrangements. At the end of January 2020, the Company ceased to rent offices, with all employees working remotely. Currently, where needed, all business meetings are held using video conferencing platforms. The Company sees that for the foreseeable future, this will now be standard operational practice. Catenae's technical solutions continue to be used effectively with customers and partners, an approach which contributes to the Company's resilience in the current circumstances.

Β 

Board and management

Β 

Catenae welcomed Brian Thompson and John Farthing to the Board as Non-executive Chairman and Chief Financial Officer, respectively, on 24 April 2020. Their wealth of experience, expertise and business network will add considerable benefit to the Company as we execute our strategy going forward.

Β 

Kevin Everett, Interim Non-executive Chairman since 17 July 2019 and Non-executive Director since 16 May 2013, stepped down from his role on 24 April 2020 to pursue other business interests. On behalf of the Board, I would like to thank Kevin for his hard work and support during an important period.

Β 

Outlook

Β 

Catenae has entered H2 2020 in a stable position and with a streamlined and resilient business model to capitalise on the opportunities that are presenting themselves. The COVID-19 pandemic presents us all with an unprecedented challenge, however the Group is confident in its ability to continue to provide its customers and partners with its technical solutions in an efficient manner.

Β 

The Company has a pipeline of opportunities ahead to expand its network of clients and to provide its technical solutions to a wider audience, and the Board looks forward to updating the market on its progress in due course.

Β 

Guy Meyer

Interim Chief Executive Officer

Β 

Β 

STATEMENT OF COMPREHENSIVE INCOME

Β 

Β 

Unaudited

six months ended

31 March

2020

Β 

Β£

Unaudited

six months ended

31 March

2019

Β 

Β£

Audited

year

ended

30 Sept

2019

Β 

Β£

Β 

Revenue

Β 

19,892

Β 

68,857

Β 

102,549

Β 

Cost of sales

Β 

-

Β 

-

Β 

-

Β 

Gross profit

Β 

19,892

Β 

68,857

Β 

102,549

Β 

Administrative expenses

Β 

(360,615)

Β 

(572,134)

Β 

(1,072,233)

Β 

Β 

Β 

Β 

Β 

(340,723)

(503,277)

(969,684)

Β 

Loss from operations

Β 

(340,723)

Β 

(503,277)

Β 

(969,684)

Β 

Net Finance income/(expense)

Β 

(23,290)

Β 

44

Β 

(1,412)

Β 

Β 

Β 

Β 

Β 

Loss before taxation

Β 

(364,013)

Β 

(503,233)

Β 

(971,096)

Β 

Taxation credit

Β 

-

Β 

-

Β 

145,866

Β 

Total comprehensive loss for the year

Β 

(364,013)

Β 

(503,233)

Β 

(825,230)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

STATEMENT OF FINANCIAL POSITION

Β 

Β 

Β 

Β 

Unaudited

six months

ended

31 March

2020

Β 

Β£

Unaudited

six months

ended

31 March

2019

Β 

Β£

Audited

year

ended

30 Sept

2019

Β 

Β£

Non-current assets

Β 

Β 

Β 

Β 

Intangible assets

Β 

1

1

1

Β 

Β 

1

1

1

Β 

Current assets

Β 

Β 

Β 

Β 

Β 

Trade and other receivables

Β 

15,161

101,394

22,948

Cash and cash equivalents

Β 

910

319,146

29,508

Β 

Β 

16.071

420,540

52,456

Current liabilities

Β 

Β 

Β 

Β 

Trade and other payables

Β 

(549,912)

(651,530)

(555,629)

Interest-bearing loans

Β 

-

(169,001)

(223,905)

Β 

Β 

(549,912)

(820,531)

(779,534)

Β 

Β 

Β 

Β 

Β 

Net Liabilities

Β 

(533,840)

(399,980)

(727,077)

Β 

Β 

Β 

Β 

Β 

Β 

Capital and reserves attributable to equity holders of the company

Β 

Β 

Β 

Β 

Β 

Share capital

Β 

Β 

Β 

3,373,601

Β 

3,173,601

Β 

3,223,601

Share premium account

Β 

17,439,221

17,068,371

17,031,971

Shares to be issued

Β 

-

18,7000

-

Share reserve

Β 

(83,333)

(83,333)

(83,333)

Merger reserve

Β 

11,119,585

11,119,585

11,119,585

Capital Redemption Reserve

Β 

2,732,904

2,732,904

2,732,904

Retained losses

Β 

(35,115,818)

(34,429,808)

(34,751,805)

Β 

Total Equity

Β 

Β 

(533,840)

Β 

(399,980)

Β 

(727,077)

Β 

Β 

Β 

STATEMENT OF CASH FLOWS

Β 

Β 

Unaudited

six months

ended

31 March 2020

Β 

Β£

Unaudited

six months

ended

31 March 2019

Β 

Β£

Audited

year

ended

30 Sept 2019

Β 

Β£

Β 

Loss for the period

Β 

(364,013)

Β 

(503,233)

Β 

(825,230)

Adjustments for:

Β 

Β 

Β 

Net bank and other interest (income) / charges

Β 

23,290

Β 

(44)

Β 

1,412

Issue of share options / warrant charge

-

-

-

Services settled by the issue of shares

-

63,782

120,055

Β 

Net (loss) before changes in working capital

Β 

Β 

(340,723)

Β 

Β 

(439,495)

Β 

Β 

(703,763)

(Increase) / decrease in trade and other receivables

Β 

7,787

Β 

(52,530)

Β 

(6,000)

(Decrease) / increase in trade and other

payables

Β 

154,628

Β 

(22,720)

Β 

(182,976)

Β 

Cash from operations

Β 

(178,308)

Β 

(514,745)

Β 

(892,739)

Β 

Interest received

Β 

10

Β 

44

Β 

88

Interest paid

(23,300)

-

(1,500)

Net cash flows from operating activities

Β 

(201,598)

Β 

(514,701)

Β 

(894,151)

Β 

Investing activities

Β 

Β 

Β 

Investment in joint venture

-

-

-

Net cash flows from investing activities

Β 

-

Β 

-

Β 

-

Β 

Financing Activities

Β 

Β 

Β 

Issue of ordinary share capital

153,000

931,403

967,810

Repayment of loans

-

(210,842)

(245,937)

New loans raised

20,000

64,181

152,681

Net cash flows from financing activities

Β 

173,000

Β 

784,742

Β 

874,554

Β 

Β 

Β 

Β 

Β 

Net increase / (decrease) in cash

Β 

(28,598)

Β 

270,041

Β 

(19,597)

Cash and cash equivalents at beginning of period

Β 

29,508

Β 

49,105

Β 

49,105

Cash and cash equivalents at end of period

Β 

910

Β 

319,146

Β 

29,508

Β 

Β 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Interim Chief Executive Officer of the Company.

Β 

Β 

Β 

Β 

- Ends -

Β 

Β 

For further information please contact:

Β 

Catenae Innovation PLC

+44 (0)191 580 8545

Guy Meyer, Interim Chief Executive Officer

Β 

Β 

Β 

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray / Jo Turner

Β 

Β 

Β 

Brandon Hill Capital Limited, Broker

+44 (0)20 3463 5000

Andy Gutmann

+44 (0)78796 8313

Β 

Β 

Yellow Jersey PR (PR & IP)

+44 (0)20 3004 9512

Sarah Hollins / Annabel Atkins

Β 

Β 

Β 

Forward-Looking Statements

Β 

Certain statements made in this announcement are forward-looking statements. These forward-looking statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections about its industry; its beliefs; and assumptions. Words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors, some of which are beyond the Company's control, are difficult to predict, and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. The Company cautions security holders and prospective security holders not to place undue reliance on these forward-looking statements, which reflect the view of the Company only as of the date of this announcement. The forward-looking statements made in this announcement relate only to events as of the date on which the statements are made. The Company will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances, or unanticipated events occurring after the date of this announcement except as required by law or by any appropriate regulatory authority.

Β 

Β 

Notes to Editors:

Β 

About Catenae Innovation PLC

Catenae Innovation is an AIM quoted provider of digital media and technology services. The Company specialises in Distributed Ledger Technology solutions that solve commercial challenges and create opportunities for its clients. The Company has an experienced IT team of project managers and integrators who have deployed systems across corporate, government and educational sectors.

Β 

www.catenaeinnovation.com

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
IR FLFEDRVIAFII
Date   Source Headline
1st Jul 20203:12 pmRNSTotal Voting Rights
1st Jul 20202:06 pmRNSSecond Price Monitoring Extn
1st Jul 20202:00 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSCompletion of Cov-ID Project
30th Jun 20207:01 amRNSHalf-year Report
30th Jun 20207:00 amRNSFinal Results
26th Jun 20204:30 pmRNSExercise of Warrant
23rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20204:36 pmRNSPrice Monitoring Extension
19th Jun 20207:00 amRNSCov-ID Project Update
12th Jun 20209:58 amRNSIssue of Equity
11th Jun 20202:02 pmRNSShare Price Movement and Update
10th Jun 202012:30 pmRNSExercise of Warrant, Conversion & Issue of Equity
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
29th May 202012:24 pmRNSHolding(s) in Company
29th May 20207:00 amRNSAgreement with Newcastle Premier Health Ltd
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
21st May 20207:00 amRNSExercise of Warrant and Issue of Equity
18th May 20207:00 amRNSCov-ID Project Update
14th May 202012:49 pmRNSResult of General Meeting and Issue of Equity
1st May 20209:00 amRNSUpdate - Cov-ID Project
29th Apr 20205:09 pmRNSPosting of Circular and Notice of General Meeting
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSDirectorate Changes
23rd Apr 202012:19 pmRNSHolding(s) in Company
21st Apr 20202:05 pmRNSSecond Price Monitoring Extn
21st Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 20203:32 pmRNSConditional Placing to raise £320,000 and Update
17th Apr 20207:00 amRNSCatenae joins Consortium on Cov-ID Project
16th Apr 20205:30 pmRNSChange of Broker
31st Mar 20202:45 pmRNSHolding(s) in Company
31st Mar 20202:40 pmRNSHolding(s) in Company
31st Mar 20202:35 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNSAnnual Report, Trading & COVID-19 Update
26th Mar 202012:49 pmRNSWorking Capital Facility
31st Jan 20201:36 pmRNSIssue of Equity & Proposed Directorate Change
24th Jan 20201:20 pmRNSUpdate re Working Capital & Balance Sheet
10th Jan 202012:23 pmRNSUpdate re Working Capital & Balance Sheet
23rd Dec 201911:37 amRNSResult of General Meeting
20th Dec 20195:02 pmRNSUpdate re Working Capital
20th Dec 20191:23 pmRNSFurther re Share Capital & Timetable Update
20th Dec 20197:00 amRNSShare Capital and Total Voting Rights
19th Dec 20197:00 amRNSFurther re Agreements and update
6th Dec 201910:53 amRNSPosting of Circular and Notice of General Meeting
12th Sep 201910:50 amRNSHolding(s) in Company
11th Sep 20197:30 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.